Contributors

ALBRECHT STENZINGER, MD
Institute of Pathology, University Hospital Heidelberg, Im Neuenheimer Feld 224, D-69120, Heidelberg, Germany

AMEER ELAIMY, PHD
Department of Medicine, University of Massachusetts Medical School, Worcester, MA, USA

ANETTE DUENSING, MD
Precision Oncology of Urological Malignancies, Department of Urology, University Hospital Heidelberg, Im Neuenheimer Feld 517, D-69120 Heidelberg, Germany and Cancer Therapeutics Program, UPMC Hillman Cancer Center, University of Pittsburgh School of Medicine, 5117 Centre Avenue, Pittsburgh, PA 15213, USA

ANIL KAPOOR, MD
Department of Surgery, McMaster University, Hamilton, Ontario, Canada

BENJAMIN A. TEPLY, MD
Division of Hematology/Oncology, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, USA

BRIAN LEWIS, PHD
Department of Molecular Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA, USA

CATHLEEN NIENTIEDT, MD
Department of Medical Oncology, University Hospital Heidelberg and National Center for Tumor Diseases (NCT), Im Neuenheimer Feld 460, D-69120 Heidelberg, Germany

CLÁUDIO J MAIA, PHD
Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Covilhã, Portugal

DAMU TANG, MSC, PHD
Department of Surgery, McMaster University, Hamilton, Ontario, Canada

DANIELLE WHITING, MRCS
Urology Department, Frimley Park Hospital, Portsmouth Rd, Frimley, Camberley GU16 7UJ, UK

DANNAH R. MILLER, PHD
Department of Pharmacology, University of Colorado Anschutz Medical Campus, Aurora, CO, USA

JINGYI PENG, BSC
Department of Surgery, McMaster University, Hamilton, Ontario, Canada

JORGE BARROCA-FERREIRA, MSC
Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Covilhã, Portugal

KENG LIM NG, MBBS, PHD, FRCS
Urology Department, Frimley Park Hospital, Portsmouth Rd, Frimley, Camberley GU16 7UJ, UK

KRITI MITTAL, MD
Department of Hematology Oncology, University of Massachusetts Medical School, Worcester, MA, USA

LUÍS A PASSARINHA, PHD
Unidade de Ciências Biomoleculares Aplicadas, Departamento de Química, Faculdade de Ciências e Tecnologia, Universidade Nova de Lisboa, Caparica, Portugal

MACHABA MICHAEL SATHEKGE, MBCHB, M MED, FAMS, PHD
Department of Nuclear Medicine, University of Pretoria/Steve Biko Academic Hospital, Pretoria, South Africa

MARCUS RUSCETTI, PHD
Department of Molecular Cell and Cancer Biology, University of Massachusetts Medical School, Worcester, MA, USA

MARIZA VORSTER, MBCHB, MMED, MPHARMMED, FCNP, PHD
Department of Nuclear Medicine, University of Pretoria/Steve Biko Academic Hospital, Pretoria, South Africa

MARKUS HOHENFELLNER, MD
Department of Urology, University Hospital Heidelberg and National Center for Tumor Diseases (NCT) Heidelberg, Im Neuenheimer Feld 420, D-69120 Heidelberg, Germany

MATTHEW A. INGERSOLL, PHD
Department of Pharmacology, Creighton University, Omaha, NE, USA

MING-FONG LIN, PHD
Department of Biochemistry and Molecular Biology, College of Medicine, University of Nebraska Medical Center, Omaha, NE, USA

MIRIAM TEROERDE, MD
Molecular Urooncology, Department of Urology, University Hospital Heidelberg, Im Neuenheimer Feld 517, D-69120 Heidelberg, Germany

MITCHELL SOKOLOFF, MD
Department of Urology, University of Massachusetts Medical School, Worcester, MA, USA

PIERRE MAJOR, MD
Department of Oncology, McMaster University, Hamilton, Ontario, Canada

SANDRA M ROCHA, MSC
Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Covilhã, Portugal

SÍLVIA SOCORRO, PHD
Centro de Investigação em Ciências da Saúde, Universidade da Beira Interior, Covilhã, Portugal

SIMON RJ BOTT, MD, FRCS, FEBU
Urology Department, Frimley Park Hospital, Portsmouth Rd, Frimley, Camberley GU16 7UJ, UK

SIMONE GIONA, MD
Urology Department, Frimley Park Hospital, Portsmouth Rd, Frimley, Camberley GU16 7UJ, UK

STEFAN DUENSING, MD
Molecular Urooncology, Department of Urology, University Hospital Heidelberg, Im Neuenheimer Feld 517, D-69120 Heidelberg, Germany

TAO WANG, PHD
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester, MA, USA

THOMAS J. FITZGERALD, MD
Department of Radiation Oncology, University of Massachusetts Medical School, Worcester, MA, USA

TOBY B.J. MURRAY, MD, MSC, MSCR
Urology Department, Frimley Park Hospital, Portsmouth Rd, Frimley, Camberley GU16 7UJ, UK

XIAOZENG LIN, PHD
Department of Surgery, McMaster University, Hamilton, Ontario, Canada

YAN GU, BSC
Department of Surgery, McMaster University, Hamilton, Ontario, Canada